Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001493152-26-034564
Filing Date
2026-07-24
Accepted
2026-07-24 16:05:39
Documents
17
Effectiveness Date
2026-07-24

Document Format Files

Seq Description Document Type Size
1 S-8 forms-8.htm S-8 97446
2 EX-5.1 ex5-1.htm EX-5.1 15387
3 EX-23.1 ex23-1.htm EX-23.1 2966
4 EX-23.2 ex23-2.htm EX-23.2 3017
5 EX-99.3 ex99-3.htm EX-99.3 8773
6 EX-FILING FEES ex107.htm   iXBRL EX-FILING FEES 16169
7 GRAPHIC ex5-1_001.jpg GRAPHIC 3902
8 GRAPHIC ex5-1_002.jpg GRAPHIC 1737
  Complete submission text file 0001493152-26-034564.txt   271871

Data Files

Seq Description Document Type Size
20 EXTRACTED XBRL INSTANCE DOCUMENT ex107_htm.xml XML 4891
Mailing Address 2 INTERNATIONAL PLAZA DR., SUITE 510 NASHVILLE TN 37217
Business Address 2 INTERNATIONAL PLAZA DR., SUITE 510 NASHVILLE TN 37217 949-409-7600
Insight Molecular Diagnostics Inc. (Filer) CIK: 0001642380 (see all company filings)

EIN.: 271041563 | State of Incorp.: CA | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-297677 | Film No.: 261201538
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
(CF Office: 03 Life Sciences)